Related Experiment Video

Updated: Jul 6, 2026

Depletion and Reconstitution of Macrophages in Mice
08:50

Depletion and Reconstitution of Macrophages in Mice

Published on: August 1, 2012

Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes

J Rugtveit1, P Brandtzaeg, T S Halstensen

  • 1Department A, University of Oslo, National Hospital, Rikshospitalet, Norway.

Gut
|May 1, 1994
PubMed

Insights

Inflammatory bowel disease (IBD) shows increased L1+ macrophages (calprotectin) in inflamed mucosa. These macrophages, distinct from RFD7+ cells, may originate from blood monocytes and contribute to non-specific defense in Crohn's disease and ulcerative colitis.

Area of Science:

  • Gastroenterology
  • Immunology
  • Cell Biology

Background:

  • Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, involves complex immune dysregulation.
  • Macrophages play a critical role in mucosal inflammation and tissue repair.

Purpose of the Study:

  • To characterize macrophage subsets in the inflamed and normal intestinal mucosa.
  • To investigate the role of L1 antigen (calprotectin) expressing macrophages in IBD.

Main Methods:

  • Paired immunofluorescence staining was performed on mucosal biopsies from patients with active IBD and healthy controls.
  • Macrophage subsets were identified using CD68, L1 antigen (calprotectin), and RFD7 antibody.

Main Results:

  • In normal mucosa, CD68+ macrophages expressing L1 antigen (calprotectin) were rare (<10%).
  • In inflamed IBD mucosa, the CD68+L1+ macrophage fraction significantly increased, especially near ulcers (median 65%).
  • L1+ macrophages were distinct from RFD7+ macrophages, suggesting a different origin, likely peripheral blood monocytes.

Conclusions:

  • L1+ macrophages, expressing calprotectin, are significantly elevated in active IBD.
  • These macrophages are likely recruited from peripheral blood monocytes.
  • L1+ macrophages may contribute to non-specific mucosal defense mechanisms in IBD due to calprotectin's antimicrobial and anti-proliferative properties.

More Related Videos

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation07:05

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages09:57

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Published on: August 12, 2019

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...